Takeda Pharmaceutical Co's logo is seen at its new headquarters in Tokyo. Photo: REUTERS file
national

Takeda-led COVID-19 plasma treatment enters clinical trial with first patient

17 Comments

The requested article has expired, and is no longer available. Any related articles, and user comments are shown below.

© Thomson Reuters 2020.

©2020 GPlusMedia Inc.

17 Comments
Login to comment

The ra$e is on!

its great, but it does take time for 10 year testing.

-2 ( +4 / -6 )

What's a rase?

2 ( +5 / -3 )

Race for the money from selling vaccines!

3 ( +8 / -5 )

Sounds like the person who makes the best product the fastest makes the most money. That's capitalism. Is capitalism good or bad?

4 ( +6 / -2 )

Rushed to market without proper trials, I won’t be putting it in my body thank you very much

-3 ( +5 / -8 )

Takeda is an American company nowadays. Just look at the shareholders data and executive leaders.

Thanks, God for those foreign executives in Takeda getting rid of over-the-counter pharmas and other unwanted assets. Stereotypical for Japanese companies, and hilariously inefficient plus unprofitable.

4 ( +5 / -1 )

Any country doctor can give you plasma treatments. What this is is an attempt to monetize the practice.

Why are studies on blood plasma low quality? Because these people could not see a way to monetize it. But they are working on that now.

It would be nice if these people could just care about our health, but that is obviously too much to ask.

0 ( +6 / -6 )

Rushed to market without proper trials, I won’t be putting it in my body thank you very much

Rushed to comment without reading the article, or even the title?

3 ( +8 / -5 )

The advantage of plasma method is that its safe compared to vaccines and drugs, the worst case scenario is that it has no efficacy.

0 ( +5 / -5 )

The race is which Big Pharma company can get so much money they can have solid gold bathtubs with legal protection from being sued.

-3 ( +3 / -6 )

There are Very Cheap Drugs instead of the Politicised Fauci Backed Remdesivir where the cost is over $3000 a Course.

Whereas we have alternatives that have been around for decades dirt cheap and do the same thing.

Gillead Sciences is basically owned by teh Chinese Communist Party through different groups. Amazing Fauci is pushing it.

-5 ( +2 / -7 )

I wonder if you can get the same thing at a discount in Mexico? :-)

1 ( +3 / -2 )

Takeda's goodwill and intangible assets are 66% of its total assets and I think its management seems to take dangerous bets. Its share price has not been so good recently. (Some investors seem to worry about abrupt impairment loss.)

Anyway, the shareholding rate of foreigners was 46% at the end of March 2020 and Takeda acquired an Irish company, so, it is difficult to call Takeda the "American" company. And I think "American" should not be highlighted in the topic of the Covid-19 due to its death toll.

0 ( +0 / -0 )

Thanks, God for those foreign executives in Takeda getting rid of over-the-counter pharmas and other unwanted assets. Stereotypical for Japanese companies, and hilariously inefficient plus unprofitable

Yeah, i don't know which one is worse, many american companies (and their made in america) products are reaching rock bottom in terms of quality: boeing, harley, gibson, dodge, jeep...and talking about american health, american pharma...probably i'm not going to trust medical companies controlled by greedy-american-pharma-executives

2 ( +2 / -0 )

If successful, please Do Not allow trump, a family member or any trump company or affiliate access to your cure.

0 ( +0 / -0 )

"Takeda is an American company nowadays. Just look at the shareholders data and executive leaders."

Not according to this:

"https://www.marketscreener.com/quote/stock/TAKEDA-PHARMACEUTICAL-COM-6491073/company/"

Having a foreigner for a CEO and a few more foreign faces on the Board doesn't equate to ownership.

-1 ( +0 / -1 )

Anyway, the shareholding rate of foreigners was 46% at the end of March 2020 and Takeda acquired an Irish company, so, it is difficult to call Takeda the "American" company. And I think "American" should not be highlighted in the topic of the Covid-19 due to its death toll.

It was at 51% last year, but it is now 46% due to the Shire acquisition. Many other foreign investors see the price too huge to pull out, and Takeda is taking up huge debts, so the stocks go to Japanese financial companies as collaterals.

Most of the important positions in Takeda are being taken by foreigners.

Yeah, i don't know which one is worse, many american companies (and their made in america) products are reaching rock bottom in terms of quality: boeing, harley, gibson, dodge, jeep...and talking about american health, american pharma...probably i'm not going to trust medical companies controlled by greedy-american-pharma-executives

I have quite a huge doubt on the acquisition of Shire. It seems to be too overpriced for me. Perhaps, the foreign executives are swindling the Japanese assets and funds to buy foreign firms at extreme prices. To boost up the stocks, then afterward the foreign investors sell all the Takeda stocks at the high prices, while leaving the company in ruins with huge debts.

Americans have been doing this type of shiet for years.

0 ( +0 / -0 )

Login to leave a comment

Facebook users

Use your Facebook account to login or register with JapanToday. By doing so, you will also receive an email inviting you to receive our news alerts.

Facebook Connect

Login with your JapanToday account

User registration

Articles, Offers & Useful Resources

A mix of what's trending on our other sites